Barcelona, Spain – A study led by the University of Barcelona and the Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) reveals how a new mechanism could improve the efficiency of currently available treatments for diabetes. The study, carried out on mice and cell cultures, may open...
research News
Bath, England – Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumour, enabling clinicians to decide how to target treatment in a more precise way. In cancers such as clear cell renal cell carcinoma (ccRCC), responses to existing treatments are different for...
Birmingham, England – The mystery of why myeloid leukaemias start to grow again after chemotherapy has killed the bulk of malignant cells, and how growth may be blocked by repurposed drugs, has potentially been solved through new research. The bone marrow of AML patients contains a rare population of leukaemic...
Vancouver, Canada – A discovery by researchers at the University of British Columbia promises to improve care for patients with endometrial cancer, the most common gynecologic malignancy. Using artificial intelligence (AI) to spot patterns across thousands of cancer cell images, the researchers have pinpointed a distinct subset of endometrial cancer...
San Diego, Calif. – A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis. The new method, called digital DNA melting analysis, can produce results in under six hours, whereas culture typically...
Cambridge, UK – An increase in nightmares and hallucinations – or ‘daymares’ – could herald the onset of autoimmune diseases such as lupus, say an international team led by researchers at the University of Cambridge and King’s College London. The researchers argue that there needs to be greater recognition that...
Chicago, Illinois – Liver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly known as nonalcoholic fatty liver disease (NAFLD). Resmetirom (to be sold under the brand name Rezdiffra), received FDA approval on March 14, 2024....
Chicago, Ill. – Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body’s immunodefense system, white blood cells. In a new study published in Blood Advances, researchers from the UChicago...
San Diego, Ca – University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology (ASH) Annual Meeting, held Dec. 9-12 in San Diego, California. Trial finds new drug shows promise to treat Chronic Lymphocytic Leukemia (CLL) Phase 2 clinical trial results suggest a new drug...
Cincinnati, OH – While the overall cancer death rate has been steadily declining in the U.S. since the 1990s, death rates due to pancreatic cancer are increasing. This is especially true in pancreatic cancer that has metastasized, or spread to a different part of the body. The National Cancer Institute...